Stock Market News

3 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership.

Pfizer (PFE)

1 day Pfizer has increased prices on over 60 drugs in the U.S. as of Jan. 1 Fortune

1 day Pfizer Rises 5.6% in a Month: How Should You Play the Stock? Zacks

1 day Pharma Stock Roundup: PFE Ends Hemophilia Deal With SGMO & More Zacks

2 days Pfizer: A Step-By-Step Strategy Before Earnings Seeking Alpha

2 days The Zacks Analyst Blog Eli Lilly, J&J, AbbVie, AstraZeneca and Pfizer Zacks

2 days The Zacks Analyst Blog Berkshire Hathaway, The Home Depot, Pfizer and AMREP Zacks

2 days Pfizer (PFE) Advances While Market Declines: Some Information for Investors Zacks

2 days Top Research Reports for Berkshire Hathaway, Home Depot & Pfizer Zacks

2 days Here’s Why Pfizer (PFE) is a Strong Momentum Stock Zacks

3 days Pfizer’s 2025 Comeback: What’s Driving Growth Seeking Alpha

4 days 2025 drug price rise: Pharma companies plan to make more than 250 medicines more expensive Fast Company

4 days Sangamo Therapeutics’ stock falls the most in 16 years after Pfizer ends hemophilia pact MarketWatch

4 days Sangamo Therapeutics Stock Crashes as Pfizer Ends Hemophilia Drug Pact Yahoo Finance

4 days Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership Yahoo Finance

4 days Sangamo Plunges After Pfizer Ends Pact for Hemophilia Drug Yahoo Finance

4 days Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact Yahoo Finance

5 days Sangamo’s stock sinks 50% as Pfizer halts haemophilia A gene therapy partnership Yahoo Finance

5 days NIH settlement ‘manageable headwind’ for BioNTech, Pfizer, says Morgan Stanley Yahoo Finance

5 days 3 Reasons to Buy Pfizer Stock Like There’s No Tomorrow Yahoo Finance

5 days Sangamo stock crashes 50% after Pfizer terminates HemoA gene therapy deal Investing.com

5 days SGMO Stock Crashes as Pfizer Ends Deal for Hemophilia Candidate Zacks

5 days Pfizer ends global collaboration with Sangamo, shares drop 27% Investing.com

5 days Pfizer: One Of The Next Big AI Winners Seeking Alpha

1 week Pfizer (PFE) Suffers a Larger Drop Than the General Market: Key Insights Zacks

1 week Pharma Stock Roundup: NVO’s Obesity Study Failure, FDA Nod to PFE, LLY Zacks

1 week Pfizer: Why I’m Staying On The Sidelines Seeking Alpha

1 week Better Income Stock: Pfizer or Altria Group? Yahoo Finance

2 weeks Pfizer: Time And Patience Ran Out (Rating Downgrade) Seeking Alpha

2 weeks Should Value Investors Buy Pfizer (PFE) Stock? Zacks

2 weeks Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know Zacks

2 weeks Pfizer’s 2025 ‘Boring’ Outlook Had A Nice Surprise That Was Overlooked Seeking Alpha

2 weeks Pharma Stock Roundup: PFE’s 2025 Outlook, MRK & ABBV’s M&A Deals Zacks

2 weeks Market Digest: ACN, ATO, OGE, PFE, PNW, JCI, DASH Yahoo Finance

2 weeks Why Pfizer (PFE) Dipped More Than Broader Market Today Zacks

2 weeks Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis) Seeking Alpha

2 weeks Pfizer: I’m Short-Term Skeptical, Long-Term Positive Post 2025 Guidance Call Seeking Alpha

2 weeks Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations Zacks

3 weeks Pfizer Sets Up For A Wild Ride In 2025 Amid Looming Threats From Starboard, Kennedy Investor's Business Daily

3 weeks Final Trade: GOOG, SAIA, X, PFE YouTube

3 weeks Pfizer climbs 4% on 2025 outlook YouTube

3 weeks Comments From Trump, Pfizer CEO Hit UnitedHealth, CVS Stock Yahoo Finance

3 weeks Stocks making the biggest moves midday: Pfizer, Broadcom, Teva Pharmaceuticals and more CNBC

3 weeks Pfizer Inc. (PFE) Full-Year 2025 Financial Guidance Conference Call (Transcript) Seeking Alpha

3 weeks Guggenheim: Can see Pfizer reaching $10 billion in sales by 2030 YouTube

3 weeks Pfizer 2025 profit forecast soothes investor jitters as it pursues turnaround Investing.com

3 weeks Pfizer Stock Jumps On Mixed, But ‘Marginally Encouraging,’ 2025 Outlook Investor's Business Daily

3 weeks Stocks making the biggest moves premarket: Pfizer, Tesla, SolarEdge, Red Cat and more CNBC

3 weeks Pfizer Sees 2025 Revenue in Line With Wall Street Views The Wall Street Journal

3 weeks AbbVie Takes On Pfizer And Merck With Its Next Leg Of Growth. Will AbbVie Stock Come Back? Investor's Business Daily

3 weeks Nvidia, Evgo and Affirm fall premarket; Pfizer and SolarEdge rise Investing.com